Finafloxacin

Overview

Finafloxacin is an orally active fourth-generation fluoroquinolone broad-spectrum antibiotic . Finafloxacin exhibits stronger antibacterial activity in acidic pH environments and is not easily affected by bacterial multidrug efflux transporters. Finafloxacin is effective against a variety of extracellular pathogenic bacteria, and can also accumulate in macrophages, showing excellent antibacterial activity against intracellular Staphylococcus aureus , Listeria monocytogenes , Legionella pneumophila , Burkholderia pseudomallei , and other pathogens. Finafloxacin has been approved by the U.S. FDA for research on acute otitis externa mediated by Pseudomonas aeruginosa . Finafloxacin is also used in studies related to diseases such as melioidosis, inhalational tularemia, and inhalational plague.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Bacterial Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-13451
• CAS No.: 209342-40-5
• Molecular Formula: C20H19FN4O4
• Molecular Weight: 398.39
• Purity: 98.75%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Availability: In-stock

Source

Original product source